Clinical Trials for Waldenstrom's Macroglobulinemia Refractory

Find clinical trials for waldenstrom's macroglobulinemia refractory. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia

NCT ID: NCT05952037

This clinical trial is studying a new treatment called sonrotoclax for people with Waldenström's Macroglobulinemia (WM), a type of blood cancer. The trial is looking at how safe and effective sonro...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States, Rochester, Minnesota, United States +96 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions